Vertex lays out plan to increase access and launch non-opioid pain reliever Journavx
During its quarterly earnings presentation, Vertex said that it expects to begin shipping newly approved non-opioid pain reliever Journavx by the end of this month and is working to secure “broad stocking agreements” with national and regional pharmacy chains.
During its quarterly earnings presentation, Vertex said that it expects to begin shipping newly approved non-opioid pain reliever Journavx by the end of this month and is working to secure “broad stocking agreements” with national and regional pharmacy chains.
